Literature DB >> 21609252

Clostridium difficile infection: a comprehensive review.

Melina Kachrimanidou1, Nikolaos Malisiovas.   

Abstract

Clostridium difficile is one of the most important causes of healthcare acquired diarrhea. The disease spectrum caused by C. difficile infection ranges from mild, self-limited, illness to a severe, life-threatening colitis. The incidence of C. difficile associated disease has risen dramatically over the last decade, leading to increased research interest aiming at the discovery of new virulence factors and the development of new treatment and prevention regimens. This review summarizes the pathogenesis and changing epidemiology of C. difficile associated disease, the clinical spectrum and laboratory methods to diagnose C. difficile infection, and current treatment strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21609252     DOI: 10.3109/1040841X.2011.556598

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  50 in total

1.  CAGS Clinical Practice Committee report: the science of Clostridium difficile and surgery.

Authors:  Shahzeer Karmali; Michael Laffin; Christopher de Gara
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

2.  Increasing hand washing compliance with a simple visual cue.

Authors:  Eric W Ford; Brian T Boyer; Nir Menachemi; Timothy R Huerta
Journal:  Am J Public Health       Date:  2013-11-14       Impact factor: 9.308

3.  Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.

Authors:  Hyeun Bum Kim; Quanshun Zhang; Xingmin Sun; Gillian Beamer; Yuankai Wang; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

Review 4.  Probiotics for antibiotic-associated diarrhea: do we have a verdict?

Authors:  Iyad Issa; Rami Moucari
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.

Authors:  Toshio Ohshima; Takako Osaki; Yukari Yamamoto; Satomi Asai; Hayato Miyachi; Shigeru Kamiya
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

6.  Development of Clostridium difficile colitis in peritoneal dialysis patients treated for peritonitis.

Authors:  D F Wolfgram; D Foster; B C Astor; M R Chan
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

Review 7.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

8.  Medicines from microbiota.

Authors:  Bernat Olle
Journal:  Nat Biotechnol       Date:  2013-04       Impact factor: 54.908

Review 9.  Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Authors:  Jason Fawley; David M Gourlay
Journal:  J Surg Res       Date:  2015-12-17       Impact factor: 2.192

10.  Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.

Authors:  Chao Chen; Naveen K Doll; Gabriele Casadei; John B Bremner; Kim Lewis; Michael J Kelso
Journal:  Bioorg Med Chem Lett       Date:  2013-12-10       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.